NASDAQ:CGNX - Cognex Stock Price, News, & Analysis

Cognex trades on the NASDAQ under the ticker symbol "CGNX."

Cognex announced a quarterly dividend on Monday, October 29th. Investors of record on Friday, November 16th will be paid a dividend of $0.05 per share on Friday, November 30th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.50%. The ex-dividend date of this dividend is Thursday, November 15th. This is a boost from Cognex's previous quarterly dividend of $0.05. View Cognex's Dividend History.

Cognex's stock split on the morning of Monday, December 4th 2017. The 2-1 split was announced on Monday, October 30th 2017. The newly minted shares were payable to shareholders after the market closes on Friday, December 1st 2017. An investor that had 100 shares of Cognex stock prior to the split would have 200 shares after the split.

Cognex declared that its board has authorized a share repurchase plan on Monday, October 29th 2018, which allows the company to buyback $200,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to purchase up to 2.8% of its shares through open market purchases. Shares buyback plans are often an indication that the company's leadership believes its shares are undervalued.

Cognex Co. (NASDAQ:CGNX) posted its quarterly earnings data on Monday, October, 29th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.37 by $0.08. The scientific and technical instruments company had revenue of $232.22 million for the quarter, compared to analysts' expectations of $227.15 million. Cognex had a return on equity of 20.88% and a net margin of 18.52%. The business's quarterly revenue was down 12.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.14 EPS. View Cognex's Earnings History.

Cognex is scheduled to release their next quarterly earnings announcement on Thursday, February 21st 2019. View Earnings Estimates for Cognex.

Cognex issued an update on its fourth quarter 2018 earnings guidance on Monday, October, 29th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $180-190 million, compared to the consensus revenue estimate of $200.09 million.

12 equities research analysts have issued 12 month target prices for Cognex's shares. Their forecasts range from $40.00 to $80.00. On average, they anticipate Cognex's share price to reach $51.4636 in the next year. This suggests a possible upside of 29.8% from the stock's current price. View Analyst Price Targets for Cognex.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cognex in the last year. There are currently 1 sell rating, 5 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cognex.

News headlines about CGNX stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Cognex earned a media sentiment score of 1.2 on InfoTrie's scale. They also assigned media coverage about the scientific and technical instruments company a news buzz of 6.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the company's share price in the near term.

Cognex saw a drop in short interest during the month of November. As of November 30th, there was short interest totalling 8,739,453 shares, a drop of 23.5% from the November 15th total of 11,419,412 shares. Based on an average daily volume of 1,268,364 shares, the short-interest ratio is currently 6.9 days. Approximately 5.3% of the shares of the company are sold short. View Cognex's Current Options Chain.

Some companies that are related to Cognex include Fortive (FTV), Keysight Technologies (KEYS), Sensata Technologies (ST), Esterline Technologies (ESL), MKS Instruments (MKSI), Orbotech (ORBK), Mesa Laboratories (MLAB), Rudolph Technologies (RTEC), Hurco Companies (HURC), Universal Detection Technology (UNDT), Hickok (HICKA), Clearsign Combustion (CLIR), International Isotopes (INIS), Sypris Solutions (SYPR) and Electro-Sensors (ELSE).

Cognex's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (10.36%), Vanguard Group Inc. (8.58%), Vanguard Group Inc (8.58%), Bank of New York Mellon Corp (4.95%), Janus Henderson Group PLC (2.86%) and Neuberger Berman Group LLC (2.07%). Company insiders that own Cognex stock include Anthony Sun, Bruce Robinson J, Jeffrey Benjamin Miller, Jerry A Schneider, John J Curran, Patrick Alias, Robert Willett and Theodor Krantz. View Institutional Ownership Trends for Cognex.

CGNX stock was sold by a variety of institutional investors in the last quarter, including Deutsche Bank AG, Pictet Asset Management Ltd., Renaissance Technologies LLC, FMR LLC, JPMorgan Chase & Co., JPMorgan Chase & Co., Mitsubishi UFJ Trust & Banking Corp and Pinnacle Associates Ltd.. Company insiders that have sold Cognex company stock in the last year include Anthony Sun and Jerry A Schneider. View Insider Buying and Selling for Cognex.

CGNX stock was bought by a variety of institutional investors in the last quarter, including Federated Investors Inc. PA, Alliancebernstein L.P., Standard Life Aberdeen plc, Standard Life Aberdeen plc, Bank of New York Mellon Corp, Nordea Investment Management AB, Riverbridge Partners LLC and DekaBank Deutsche Girozentrale. View Insider Buying and Selling for Cognex.

Shares of CGNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CGNX stock can currently be purchased for approximately $39.66.

Cognex has a market capitalization of $6.85 billion and generates $747.95 million in revenue each year. The scientific and technical instruments company earns $177.17 million in net income (profit) each year or $1.45 on an earnings per share basis. Cognex employs 1,771 workers across the globe.

The official website for Cognex is http://www.cognex.com.

Cognex's mailing address is ONE VISION DRIVE, NATICK MA, 01760. The scientific and technical instruments company can be reached via phone at 508-650-3000 or via email at [email protected]